• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2005年至2011年波兰冠状动脉疾病经皮治疗的时间趋势和模式

Temporal trends and patterns in percutaneous treatment of coronary artery disease in Poland in the years 2005-2011.

作者信息

Siudak Zbigniew, Ochała Andrzej, Lesiak Maciej, Witkowski Adam, Gil Robert J, Legutko Jacek, Maciejewski Paweł, Fijorek Kamil, Dudek Dariusz

机构信息

Uniwersytet Jagiellonski Collegium Medicum.

出版信息

Kardiol Pol. 2015;73(7):485-92. doi: 10.5603/KP.a2015.0037. Epub 2015 Mar 3.

DOI:10.5603/KP.a2015.0037
PMID:25733178
Abstract

BACKGROUND

According to a recent survey, Poland is one of the leaders of interventional cardiology in Europe in terms of the number of primary percutaneous coronary intervention (PCI) procedures per million inhabitants.

AIM

To present temporal trends in epidemiology, demographics, treatment, and periprocedural outcome of patients referred for percutaneous coronary angiography and angioplasty in Poland in 2005-2011, based on the Polish National PCI Registry.

METHODS

Patients who underwent percutaneous coronary angiography (ANGIO group) and/or angioplasty (PCI group) were included in the Polish National PCI Registry - a prospective observational registry study in Poland.

RESULTS

There were 935,429 patients in the ANGIO group and 501,117 in the PCI group in Poland in 2005-2011. The number of catheterisation labs increased from 75 to 137, angiography procedures rose from 99,195 to 180,935, and PCIs from 50,297 to 99,614. The procedural mortality and stroke rates for the ANGIO group have remained stable whereas for the PCI group procedural mortality has increased over the years. The use of drug eluting stents (DESs) rose from 32.8% to 55.3% in stable angina and the use of a radial approach from 26.8% to 39.1%.

CONCLUSIONS

Use of modern attributes of interventional cardiology like DES stents, radial approach, and treatment of higher risk patients has increased in Poland in 2005-2011. The adoption of the "Stent for Life" initiative has resulted in an increasing number of percutaneous coronary procedures over the years.

摘要

背景

根据最近的一项调查,就每百万居民的首次经皮冠状动脉介入治疗(PCI)手术数量而言,波兰是欧洲介入心脏病学的领先国家之一。

目的

基于波兰国家PCI登记处的数据,呈现2005 - 2011年波兰接受经皮冠状动脉造影和血管成形术患者的流行病学、人口统计学、治疗及围手术期结果的时间趋势。

方法

接受经皮冠状动脉造影(血管造影组)和/或血管成形术(PCI组)的患者被纳入波兰国家PCI登记处——波兰的一项前瞻性观察登记研究。

结果

2005 - 2011年波兰血管造影组有935,429例患者,PCI组有501,117例患者。导管实验室数量从75个增加到137个,血管造影手术从99,195例增加到180,935例,PCI手术从50,297例增加到99,614例。血管造影组的手术死亡率和中风率保持稳定,而PCI组的手术死亡率多年来有所上升。药物洗脱支架(DES)在稳定型心绞痛中的使用率从32.8%上升到55.3%,桡动脉途径的使用率从26.8%上升到39.1%。

结论

2005 - 2011年波兰介入心脏病学的现代技术如DES支架、桡动脉途径以及对高风险患者的治疗应用有所增加。多年来,“终身支架”倡议的采用导致经皮冠状动脉手术数量不断增加。

相似文献

1
Temporal trends and patterns in percutaneous treatment of coronary artery disease in Poland in the years 2005-2011.2005年至2011年波兰冠状动脉疾病经皮治疗的时间趋势和模式
Kardiol Pol. 2015;73(7):485-92. doi: 10.5603/KP.a2015.0037. Epub 2015 Mar 3.
2
Spanish Cardiac Catheterization and Coronary Intervention Registry. 25th Official Report of the Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology (1990-2015).西班牙心脏导管插入术与冠状动脉介入注册研究。西班牙心脏病学会心脏导管插入术与介入心脏病学工作组第25份官方报告(1990 - 2015年)
Rev Esp Cardiol (Engl Ed). 2016 Dec;69(12):1180-1189. doi: 10.1016/j.rec.2016.08.016. Epub 2016 Nov 4.
3
Stent thrombosis in new-generation drug-eluting stents in patients with STEMI undergoing primary PCI: a report from SCAAR.新一代药物洗脱支架在 STEMI 患者行直接经皮冠状动脉介入治疗中的支架血栓形成:来自 SCAAR 的报告。
J Am Coll Cardiol. 2014 Jul 8;64(1):16-24. doi: 10.1016/j.jacc.2014.04.022.
4
Drug-eluting stents and the use of percutaneous coronary intervention among patients with class I indications for coronary artery bypass surgery undergoing index revascularization: analysis from the NCDR (National Cardiovascular Data Registry).药物洗脱支架与接受首次血运重建的冠状动脉旁路移植术I类适应症患者经皮冠状动脉介入治疗的应用:来自国家心血管数据注册库(NCDR)的分析
JACC Cardiovasc Interv. 2009 Jul;2(7):614-21. doi: 10.1016/j.jcin.2009.05.001.
5
The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.血管成像在常规经皮冠状动脉介入治疗中的作用:金属裸支架和药物洗脱支架试验的荟萃分析。
Cardiovasc Ther. 2015 Dec;33(6):360-6. doi: 10.1111/1755-5922.12160.
6
Clinical outcomes in nonagenarians undergoing a percutaneous coronary intervention: data from the ORPKI Polish National Registry 2014-2016.90岁及以上老人接受经皮冠状动脉介入治疗的临床结果:来自2014 - 2016年波兰ORPKI国家注册中心的数据
Coron Artery Dis. 2018 Nov;29(7):573-578. doi: 10.1097/MCA.0000000000000649.
7
Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.性别对既往未经治疗的冠状动脉疾病患者使用裸金属支架和药物洗脱支架进行经皮冠状动脉介入治疗后3年预后的影响:来自RESEARCH(鹿特丹心脏病医院雷帕霉素洗脱支架评估)和T-SEARCH(鹿特丹心脏病医院紫杉醇支架评估)注册研究的见解
JACC Cardiovasc Interv. 2009 Jul;2(7):603-10. doi: 10.1016/j.jcin.2009.03.016.
8
Borderline trend towards long-term mortality benefit from drug eluting stents implantation in ST-elevation myocardial infarction patients in Poland-data from NRDES registry.波兰 NRDES 注册研究显示,药物洗脱支架置入术治疗 ST 段抬高型心肌梗死患者有长期死亡率获益的趋势。
Catheter Cardiovasc Interv. 2014 Feb 15;83(3):436-42. doi: 10.1002/ccd.25169. Epub 2013 Sep 23.
9
Trends in percutaneous coronary intervention from 2004 to 2013 according to the Portuguese National Registry of Interventional Cardiology.根据葡萄牙国家介入心脏病学注册中心的数据,2004年至2013年经皮冠状动脉介入治疗的趋势。
Rev Port Cardiol. 2015 Nov;34(11):673-81. doi: 10.1016/j.repc.2015.06.005.
10
Percutaneous revascularization for stable coronary artery disease temporal trends and impact of drug-eluting stents.经皮血运重建治疗稳定型冠状动脉疾病的时间趋势及药物洗脱支架的影响
JACC Cardiovasc Interv. 2010 Feb;3(2):172-9. doi: 10.1016/j.jcin.2009.11.013.

引用本文的文献

1
Clinical and procedural characteristics of COVID-19 patients treated with percutaneous coronary interventions.经皮冠状动脉介入治疗的 COVID-19 患者的临床和操作特点。
Catheter Cardiovasc Interv. 2020 Nov;96(6):E568-E575. doi: 10.1002/ccd.29134. Epub 2020 Jul 20.
2
The progress in outcomes of the management of patients with non-ST-segment elevation myocardial infarction between 2005 and 2014 in Poland - a propensity score matching analysis from the PL-ACS registry.2005年至2014年波兰非ST段抬高型心肌梗死患者管理结局的进展——来自波兰急性冠状动脉综合征(PL-ACS)注册研究的倾向评分匹配分析
Postepy Kardiol Interwencyjnej. 2020 Mar;16(1):41-48. doi: 10.5114/aic.2020.93911. Epub 2020 Apr 3.
3
Coronary Catheterization and Percutaneous Coronary Intervention in China: 10-Year Results From the China PEACE-Retrospective CathPCI Study.
中国的冠状动脉导管插入术和经皮冠状动脉介入治疗:中国PEACE-回顾性导管PCI研究的10年结果
JAMA Intern Med. 2016 Apr;176(4):512-21. doi: 10.1001/jamainternmed.2016.0166.
4
No clinical benefit from manual thrombus aspiration in patients with non-ST-elevation myocardial infarction.非ST段抬高型心肌梗死患者行手动血栓抽吸无临床获益。
Postepy Kardiol Interwencyjnej. 2016;12(1):32-40. doi: 10.5114/pwki.2016.56947. Epub 2016 Feb 11.